Acadian Asset Management LLC Atreca, Inc. Transaction History

Acadian Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$0.88 - $1.22 $19,137 - $26,531	-21,747 Reduced 33.02%	44,110 $42,000
Q1 2023 May 11, 2023	SELL	$0.91 - $1.82 $9,120 - $18,241	-10,023 Reduced 13.21%	65,857 $74,000
Q4 2022 Feb 14, 2023	BUY	$0.78 - $1.68 $42,223 - $90,943	54,133 Added 248.92%	75,880 $59,000
Q2 2022 Aug 09, 2022	BUY	$1.56 - $3.25 $33,925 - $70,677	21,747 New	21,747 $39,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.